Connect Sign In
The ARUP Consult Viral Hepatitis topic was recently updated to reflect new recommendations and guidelines for testing, including ARUP’s new triple panel test.
ARUP Laboratories has been named to the Women Tech Council’s 2025 Shatter List for its commitment to empowering employees through mentorship, leadership initiatives, and community investment.
Medical Laboratory Professionals Week (Lab Week) celebrates the vital work of clinical laboratory professionals, highlighting their role in healthcare.
Join ARUP this Lab Week in investigating the latest advancements in lab science that empower medical laboratory science (MLS) detectives to solve cases more efficiently and effectively.
ARUP is the first reference laboratory to offer a molecular measles assay that both detects the measles virus and distinguishes between infection-causing and vaccine strains of the virus.
ARUP Laboratories’ annual client satisfaction survey results highlight our exceptional customer service; over 90% of respondents said they had a favorable impression of our company.
Join ARUP at the 2025 AAN Annual Meeting to explore the latest in diagnostic laboratory testing for autoimmune neurology, including a presentation on a new biomarker test for Alzheimer's disease.
ARUP CEO Andy Theurer leads a group of university students through ARUP’s Automated Core Laboratory.
ARUP Laboratories and BioHive’s university student chapters collaborated to host a field trip at ARUP, where university students learned about laboratory science careers and toured the lab.
A comprehensive and detailed article by ARUP experts gives those responsible for anatomic pathology testing a resource for pertinent regulatory information to ensure compliance.
Recent measles outbreaks are concerning. To assist in detecting measles virus and determining immunity, ARUP currently provides testing for IgM and IgG antibodies.
Join ARUP at the 2025 ACMG annual meeting to explore the latest in laboratory genetics research, including how traditional and innovative test strategies can evaluate rare and undiagnosed cases.
Because an estimated one in 10 Americans lives with a rare disease, ARUP is committed to investing in the diagnostic research and innovation that will help bring them answers.
